Effect of Acute Immunosuppression on Left Ventricular Recovery and Mortality in Fulminant Viral Myocarditis: A Case Series and Review of Literature
Background: Fulminant viral myocarditis (FVM) is a rare cause of cardiogenic shock associated with high morbidity and mortality rates. An inappropriately activated immune system results in severe myocardial inflammation. Acute immunosuppressive therapy for FVM therefore gained in popularity and was...
Main Authors: | Pierre Yves Turgeon, MD, Montse Massot, MD, Frédéric Beaupré, MD, David Belzile, MD, Jonathan Beaudoin, MD, Mathieu Bernier, MD, Christine Bourgault, MD, Valérie Germain, BScN, Claudine Laliberté, BScN, Joëlle Morin, MD, Philippe Gervais, MD, Sylvain Trahan, MD, Éric Charbonneau, MD, François Dagenais, MD, Mario Sénéchal, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | CJC Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589790X20301840 |
Similar Items
-
Fulminant Eosinophilic Myocarditis
by: Pedro M. Lopes, MD, et al.
Published: (2020-05-01) -
SARS-CoV-2 Fulminant Myocarditis
by: Jérôme Garot, MD, PhD, et al.
Published: (2020-07-01) -
Fulminant Eosinophilic Myocarditis and VT Storm
by: Kyle R. Hoppens, MD, et al.
Published: (2021-03-01) -
Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
by: Osnat Itzhaki Ben Zadok, MD, MS, et al.
Published: (2019-09-01) -
Fulminant Bacterial Myocarditis Presenting as Myocardial Infarction
by: Cvetan Trpkov, MDCM, et al.
Published: (2020-05-01)